Showing results (1151-1160 of 1,240) with videos related to

Sort By:
Pageof 124
American Journal of Hematology|April 23, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromeEmilio Paolo Alessandrino, Matteo G Della Porta, Luca Malcovati, et al.
Blood|February 22, 2014
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-RMatteo G Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Bone Marrow Transplantation|May 27, 2026
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapyRaffaella Greco, Isabel Sánchez-Ortega, Antonio M Risitano, et al.
International Journal of Molecular Sciences|July 2, 2021
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel InflammationLuca Antonioli, Carolina Pellegrini, Matteo Fornai, et al.
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
Bone Marrow Transplantation|January 15, 2022
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Annals of Hematology|January 9, 2022
Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia majorRoswitha Lüftinger, Natalia Zubarovskaya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|February 12, 2025
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCTJakob R Passweg, Helen Baldomero, Marina Atlija, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular LymphomaStefano Luminari, Angela Ferrari, Martina Manni, et al.
Pageof 124